| Authors: |
Szczepanowski M; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. m.szczepanowski@med2.uni-kiel.de.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany. m.szczepanowski@med2.uni-kiel.de., Richter J; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Department for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bendig S; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Bastian L; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Kelm M; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Beck V; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany., Beder T; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Chitadze G; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Kotrová M; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Duell J; Department of Internal Medicine II, Würzburg University Hospital, University of Würzburg, Würzburg, Germany., Faul C; Internal Medicine II, University Hospital and Comprehensive Cancer Center Tübingen, Universitätsklinikum Tübingen, Tübingen, Germany., Gärtner J; Department of Medicine 5, Oncology, Hematology and Bone Marrow Transplantation Unit, Klinikum Nürnberg Nord, Nürnberg, Germany., Hartmann A; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Kehden B; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Penas EMM; Institute of Human Genetics, University Medical Center Schleswig- Holstein (UKSH), Campus Lübeck, Lübeck, Germany., Neumann M; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Ritgen M; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Schrader W; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Steffen B; Medicine Department II, Johann Wolfgang Goethe University, Frankfurt, Germany., Trautmann H; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Viardot A; Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany., Burmeister T; Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum, Campus Virchow Klinikum, Charité - Universitätsmedizin, Berlin, Germany.; Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin , Berlin, Germany., Baldus CD; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany., Schwartz S; Department of Hematology, Oncology and Tumor Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Gökbuget N; Medicine Department II, Johann Wolfgang Goethe University, Frankfurt, Germany., Brüggemann M; Medicine Department II, Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany.; Clinical Research Unit 'CATCH ALL' (KFO 5010), Kiel, Germany.; University Cancer Center Schleswig-Holstein (UCCSH), Campus Kiel, Kiel, Germany. |
